Enhanced Tumor Selectivity of 5-Fluorouracil Using a Reactive Oxygen Species-Activated Prodrug Approach

被引:30
作者
Ai, Yong [1 ]
Obianom, Obinna N. [1 ]
Kuser, Meredith [1 ]
Li, Yue [2 ]
Shu, Yan [1 ,3 ]
Xue, Fengtian [1 ]
机构
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20740 USA
[3] Guangzhou Med Univ, Sch & Hosp Stomatol, Guangzhou 510140, Guangdong, Peoples R China
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2019年 / 10卷 / 01期
基金
美国国家卫生研究院;
关键词
5-Fluorouracil; prodrugs; reactive oxygen species; anticancer; AMINOFERROCENE-BASED PRODRUGS; CROSS-LINKING AGENTS; HYDROGEN-PEROXIDE; CANCER-CELLS; OXIDATIVE STRESS; ROS; PHOSPHORYLASE; MECHANISMS; TOXICITY; STRATEGY;
D O I
10.1021/acsmedchemlett.8b00539
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report the design, synthesis, and evaluation of novel 5-fluorouracil (5FU) prodrugs 1a,1b that are efficiently activated by the high level of reactive oxygen species (ROS) in cancer cells. Prodrugs 1a,1b selectively kill cancer cells over normal cells and are well-tolerated in mice. The strategy described herein can extend application of chemotherapeutic drugs.
引用
收藏
页码:127 / 131
页数:9
相关论文
共 41 条
  • [1] Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1
    Arnold, RS
    Shi, J
    Murad, E
    Whalen, AM
    Sun, CQ
    Polavarapu, R
    Parthasarathy, S
    Petros, JA
    Lambeth, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) : 5550 - 5555
  • [2] Exploiting tumour hypoxia in cancer treatment
    Brown, JM
    William, WR
    [J]. NATURE REVIEWS CANCER, 2004, 4 (06) : 437 - 447
  • [3] Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis
    Cadahia, Jorge Peiro
    Bondebjerg, Jon
    Hansen, Christian A.
    Previtali, Viola
    Hansen, Anders E.
    Andresen, Thomas L.
    Clausen, Mads H.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (08) : 3503 - 3515
  • [4] Discovery and Optimization of Novel Hydrogen Peroxide Activated Aromatic Nitrogen Mustard Derivatives as Highly Potent Anticancer Agents
    Chen, Wenbing
    Fan, Heli
    Balakrishnan, Kumudha
    Wang, Yibin
    Sun, Huabing
    Fan, Yukai
    Gandhi, Varsha
    Arnold, Leggy A.
    Peng, Xiaohua
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (20) : 9132 - 9145
  • [5] Reactive Oxygen Species (ROS) Inducible DNA Cross-Linking Agents and Their Effect on Cancer Cells and Normal Lymphocytes
    Chen, Wenbing
    Balakrishnan, Kumudha
    Kuang, Yunyan
    Han, Yanyan
    Fu, Min
    Gandhi, Varsha
    Peng, Xiaohua
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4498 - 4510
  • [6] Improved Synthesis of N-Benzylaminoferrocene-Based Prodrugs and Evaluation of Their Toxicity and Antileukemic Activity
    Daum, Steffen
    Chekhun, Vasiliy F.
    Todor, Igor N.
    Lukianova, Natalia Yu
    Shvets, Yulia V.
    Sellner, Leopold
    Putzker, Kerstin
    Lewis, Joe
    Zenz, Thorsten
    de Graaf, Inge A. M.
    Groothuis, Geny M. M.
    Casini, Angela
    Zozulia, Oleksii
    Hampel, Frank
    Mokhir, Andriy
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (04) : 2015 - 2024
  • [7] Discovery of Novel N-(4-Hydroxybenzyl)valine Hemoglobin Adducts in Human Blood
    Degner, Amanda
    Carlsson, Henrik
    Karlsson, Isabella
    Eriksson, Johan
    Pujari, Suresh S.
    Tretyakova, Natalia Y.
    Tornqvist, Margareta
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2018, 31 (12) : 1305 - 1314
  • [8] Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
    Dharmaraja, Allimuthu T.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (08) : 3221 - 3240
  • [9] Arylboronate Ester Based Diazeniumdiolates (BORO/NO), a Class of Hydrogen Peroxide Inducible Nitric Oxide (NO) Donors
    Dharmaraja, Allimuthu T.
    Ravikumar, Govindan
    Chakrapani, Harinath
    [J]. ORGANIC LETTERS, 2014, 16 (10) : 2610 - 2613
  • [10] ELSAYED YM, 1983, CANCER RES, V43, P4039